Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
19942.6k citationsDaniël Hoyer, David E. Clarke et al.Pharmacological Reviewsprofile →
Molecular, pharmacological and functional diversity of 5-HT receptors
20021.5k citationsDaniël Hoyer, Jason Hannon et al.profile →
This map shows the geographic impact of Daniël Hoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël Hoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël Hoyer more than expected).
This network shows the impact of papers produced by Daniël Hoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël Hoyer. The network helps show where Daniël Hoyer may publish in the future.
Co-authorship network of co-authors of Daniël Hoyer
This figure shows the co-authorship network connecting the top 25 collaborators of Daniël Hoyer.
A scholar is included among the top collaborators of Daniël Hoyer based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Daniël Hoyer. Daniël Hoyer is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Coleman, Paul J., Luı́s de Lecea, Anthony L. Gotter, et al.. (2021). Orexin receptors in GtoPdb v.2021.3. IUPHAR/BPS Guide to Pharmacology CITE. 2021(3).3 indexed citations
Vacher, Claire‐Marie, Martin Gassmann, Sandrine Desrayaud, et al.. (2006). Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. HAL (Le Centre pour la Communication Scientifique Directe).3 indexed citations
12.
Hoyer, Daniël, Markus Schmutz, Ron Maier, et al.. (2005). mGluR7 plays a key role in the modulation of anxiety behavior: Evidence from mGluR7-knockout mice and siRNA-induced knockdown in the adult mouse brain. Neuropharmacology. 49.3 indexed citations
13.
Weckbecker, Gisbert, et al.. (2005). Opportunities in somatostatin research: Biological, chemical and therapeutic aspects (vol 2, pg 999, 2003). Nature Reviews Drug Discovery. 4(12).2 indexed citations
Hannon, Jason & Daniël Hoyer. (2002). Serotonin receptors and systems: endless diversity?. Acta Biologica Szegediensis. 46. 1–12.21 indexed citations
16.
Nunn, Caroline, Dominik Feuerbach, Xi Lin, Richard Peter, & Daniël Hoyer. (2001). Functional expression and pharmacological characterisation of the goldfish somatostatin sst5 receptor. British Journal of Pharmacology. 134. 42.2 indexed citations
17.
Siehler, Sandra, Klaus Seuwen, & Daniël Hoyer. (1998). [I-125][Tyr(3)]octreotide labels human somatostatin sst(2) and sst(5) receptors. European Journal of Pharmacology. 348.2 indexed citations
18.
Hoyer, Daniël, et al.. (1997). Pharmacological profile of human 5-hydroxytryptamine 5-HT7 receptors expressed in insect cells using the baculovirus system. British Journal of Pharmacology. 120.1 indexed citations
19.
Hoyer, Daniël, David E. Clarke, John R. Fozard, et al.. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).. Pharmacological Reviews. 46(2). 157–203.2558 indexed citations breakdown →
20.
Engel, Günther, Daniël Hoyer, R. Berthold, & Henry R. Wagner. (1980). (±)-Iodocyanopindolol (125 ICYP), a potent, highly specific ligand for β-adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 311.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.